Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Matrilin-4 (MATN4) is a protein encoded by the MATN4 gene and is a major component of the extracellular matrix, especially in cartilage[3][6]. It is part of the von Willebrand factor A domain–containing protein family, which plays a role in forming filamentous networks that provide structural support to tissues such as cartilage and cornea[2][3][6]. Matrilin-4 is implicated in extracellular matrix organization, cartilage matrix formation, and tissue regeneration, including potential roles in corneal dystrophies and wound healing[2][3]. Alternative splicing results in multiple transcript variants, but there is currently no evidence that MATN4 is a therapeutic target for approved drugs or that it acts as a receptor, enzyme, or transporter in pharmacological contexts[2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Matrilin-4 (MATN4).